Trial Profile
Efficacy of 8 versus 12 week Ledipasvir/sofosbuvir in treatment-naive non-cirrhotic patients with genotype 1 HCV infection: A Real-world study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 31 Jan 2017 New trial record